Thursday, November 15, 2012

• Calcalist: Teva is leading candidate to buy Amarin, Reuters reportsat theflyonthewall.com (Thu, Nov 15)

Wednesday, November 14, 2012

• Can You Double Your Money with Dynavax?at Motley Fool (Wed, Nov 14)
• Who Will Pioneer the New Diabetes Market?at Motley Fool (Wed, Nov 14)
• 3 Potential Partners for Amarinat Motley Fool (Wed, Nov 14)
• Teva Is Still Healthier Than Its Big Pharma Peersat Seeking Alpha (Wed, Nov 14)
• EU OKs Bristol-Myers, AstraZeneca diabetes drugAP (Wed, Nov 14)
• 1 Reason to Buy Amarin Right Now, and 1 Reason to Sellat Motley Fool (Wed, Nov 14)
• Forxiga™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 DiabetesBusiness Wire (Wed, Nov 14)
• Forxiga™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 DiabetesBusiness Wire (Wed, Nov 14)

Tuesday, November 13, 2012

• Is This Diabetes Drug Merck's Next Blockbuster?at Motley Fool (Tue, Nov 13)
• 2 Speculative Biotech Plays Making Significant Stridesat Seeking Alpha (Tue, Nov 13)
• AstraZeneca: German court voids Seroquel XR patentAP (Tue, Nov 13)
• Down 14%, FDA Concerns Crush Nektarat Motley Fool (Tue, Nov 13)
• EU Nod for Novartis' VotubiaZacks (Tue, Nov 13)
• AstraZeneca, Nektar Opioid Constipation Drug May Have Failed Phase III Studyat TheStreet (Tue, Nov 13)
• Why Nektar Therapeutics' Shares Tumbledat Motley Fool (Tue, Nov 13)
• Consider Ironwood Pharmaceuticals Amidst Strong Insider Supportat Seeking Alpha (Tue, Nov 13)

Monday, November 12, 2012

• 5 Dividend Stocks That Should Flourish In 2013at Seeking Alpha (Mon, Nov 12)
• Dynavax Upcoming Binary Event: HBV Vaccine Under Review By FDA Advisory Panelat Seeking Alpha (Mon, Nov 12)
• AstraZeneca Launches New Digital Resources for ARIMIDEX® (anastrozole) Tablets to Help Educate Patients About ARIMIDEX DirectBusiness Wire (Mon, Nov 12)
• FDA Places New Heart-Safety Hurdle in Path of Opioid Constipation Drugsat TheStreet (Mon, Nov 12)
• How to Choose a Big Pharma Stockat Motley Fool (Mon, Nov 12)

Saturday, November 10, 2012

• Amarin Still Playing the Dating Gameat Motley Fool (Sat, Nov 10)
• Does Amarin Need the FDA to Play NCE?at Motley Fool (Sat, Nov 10)
• Pfizer Loses Its Cash Cow!at Motley Fool (Sat, Nov 10)

Add AZN News to My Yahoo!